Version June 2024
| mCi (MBq) administered | ||||
| 50 (1850) | 100 (3700) | 150 (5550) | 200 (7400) | |
| Restricted periods | ||||
| Nighttime restrictions | ||||
| Sleep in a separate (6-feet separation) bed from adults for days¶ shown | 1 | 1 | 2 | 4 |
| Sleep in a separate bed from pregnant partners, infant, or child for days shown | 6 | 13 | 18 | 21 |
| Daytime restrictions | ||||
| You may return to work after days shown | 1 | 1 | 1 | 1 |
| Maximize your distance (6 feet) from children and pregnant persons for days shown | 1 | 1 | 1 | 1 |
| Avoid extended time in public places for days shown | 1 | 1 | 1 | 1 |
| Duration of safe travel by public transportation (bus, air, etc)Δ | ||||
| Travel time (hours) without exceeding regulatory dose limit | ||||
| Day¶ 0 (beginning with treatment) | 1.2 | 0.6 | 0.4 | 0.3 |
| Day 1 | 3.0 | 1.5 | 1.0 | 0.8 |
| Day 2 | 7.2 | 3.8 | 2.5 | 1.9 |
| Day 3 | 15.0 | 7.5 | 5.0 | 3.8 |
| Day 4 | – | 15.0 | 10.0 | 7.5 |
131-I: radioiodine.
* Assumes that disappearance of 131I is biexponential with early effective T1/2 of about 0.76 days, and 2% uptake in remnant with effective T1/2 of about 7.3 days. Consider formal dosimetry for larger administered doses given to patients with functioning carcinoma. 131I kinetics in euthyroid patients stimulated by recombinant human thyrotropin may differ from those used here.
¶ Day = 24-hour cycle.
Δ Assumes 100 mrem limit and 0.3 m distance.آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
